Health ❯ Healthcare ❯ Clinical Trials ❯ Drug Efficacy

Combination Therapy

NICE Recommends Padcev–Keytruda as First-Line NHS Treatment for Advanced Bladder Cancer

The move follows EV-302 trial evidence showing the combination nearly doubled overall survival versus platinum chemotherapy.

Paclitaxel Reengineered Into Self-Assembling Nanovesicle Shows Strong Preclinical Gains

Nature Study Shows Gut Bacterium YB328 Boosts Cancer Immunotherapy